Asthma: benchmarking for quality improvement

被引:23
作者
Stempel, DA
Carlson, AM
Buchner, DA
机构
[1] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[2] Data Intelligence Consultants LLC, Eden Prairie, MN USA
[3] Schering Plough, Integrated Therapuet Grp, Kenilworth, NJ USA
关键词
D O I
10.1016/S1081-1206(10)63059-1
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Linked medical and pharmacy claims can be used to identify patients with asthma and benchmark current practice standards. Method: This was a 3-year study of five independent practice association style health maintenance organizations with an annual enrollment of 870,000, More than 28,000 members were identified with claims for asthma. Objective: The intent of this study was to benchmark current asthma practice. Before quality improvement projects can be implemented baseline data are required. Results: The prevalence of asthma varied by geographic regions. Specialty care was associated with greater use of anti-inflammatory medications and more refills of these drugs, Refill rates for inhaled corticosteroids for all patients was low. Specialty care of asthmatic members was associated with a lower rate of emergency service events and hospitalizations. Conclusions: Linked medical and pharmacy claims' databases can be used to benchmark current practice performance and serve as a reference for quality improvement programs. Appropriate use of specialty care may improve asthma outcomes.
引用
收藏
页码:517 / 524
页数:8
相关论文
共 16 条
  • [1] THE COST AND EFFECTIVENESS OF AN EDUCATION-PROGRAM FOR ADULTS WHO HAVE ASTHMA
    BOLTON, MB
    TILLEY, BC
    KUDER, J
    REEVES, T
    SCHULTZ, LR
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 1991, 6 (05) : 401 - 407
  • [2] EFFECT OF AN INHALED CORTICOSTEROID ON AIRWAY INFLAMMATION AND SYMPTOMS IN ASTHMA
    DJUKANOVIC, R
    WILSON, JW
    BRITTEN, KM
    WILSON, SJ
    WALLS, AF
    ROCHE, WR
    HOWARTH, PH
    HOLGATE, ST
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (03): : 669 - 674
  • [3] Gergen PT, 1995, ASTHMA RHINITIS, P15
  • [4] *GLOB STRAT ASTHM, 1995, NIH PUBL
  • [5] COMPARISON OF A BETA-2-AGONIST, TERBUTALINE, WITH AN INHALED CORTICOSTEROID, BUDESONIDE, IN NEWLY DETECTED ASTHMA
    HAAHTELA, T
    JARVINEN, M
    KAVA, T
    KIVIRANTA, K
    KOSKINEN, S
    LEHTONEN, K
    NIKANDER, K
    PERSSON, T
    REINIKAINEN, K
    SELROOS, O
    SOVIJARVI, A
    STENIUSAARNIALA, B
    SVAHN, T
    TAMMIVAARA, R
    LAITINEN, LA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (06) : 388 - 392
  • [6] Homer CJ, 1996, PEDIATRICS, V98, P18
  • [7] MEASURING QUALITY-OF-LIFE IN ASTHMA
    JUNIPER, EF
    GUYATT, GH
    FERRIE, PJ
    GRIFFITH, LE
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : 832 - 838
  • [8] EFFECT OF LONG-TERM TREATMENT WITH AN INHALED CORTICOSTEROID (BUDESONIDE) ON AIRWAY HYPERRESPONSIVENESS AND CLINICAL ASTHMA IN NONSTEROID-DEPENDENT ASTHMATICS
    JUNIPER, EF
    KLINE, PA
    VANZIELEGHEM, MA
    RAMSDALE, EH
    OBYRNE, PM
    HARGREAVE, FE
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (04): : 832 - 836
  • [9] LAHDENSUO A, 1996, BRIT MED J, V312, P749
  • [10] *NAT COMM QUAL, 1996, NAT COMM QUAL ASS HL